SPEEDX
SpeeDx have announced signing two new distribution partners, creating comprehensive access for customers to market-leading SpeeDx Resistance Plus ® and Plex PCR ® tests across Europe. AB ANALITICA will distribute throughout Italy and Immuno Diagnostic Oy will cover Finland.
“Our new distribution partners have strong sales presence in their regions and close working relationships with the key customers that are interested in our solutions,” says Colin Denver, SpeeDx CEO. “Antibiotic resistance in sexually transmitted diseases is a top concern for authorities and testing bodies across Europe, and now more laboratories can access our ResistancePlus tests for Mycoplasma genitalium and gonorrhoea to help address the real need for Resistance Guided Therapy.”
The SpeeDx Resistance Plus portfolio includes Resistance Plus GC* (CE-IVD) - the first commercially available test that combines Neisseria gonorrhoeae (GC) detection with markers for ciprofloxacin susceptibility. Resistance Plus GC enables stewardship of last-line antibiotic treatments by directing therapy towards ciprofloxacin when appropriate. Ciprofloxacin is a simple oral antibiotic, and surveillance data indicates it is still effective for up to 70% of gonorrhoea infections.1-4 The market-leading Resistance Plus MG assay from SpeeDx simultaneously detects Mycoplasma genitalium and genetic markers for azithromycin resistance, with demonstrated clinical outcomes of increased patient cure rate up to 92% compared with 40% cure rates when using MG-detection-only testing.5 SpeeDx also plans to release a new Resistance Plus MG test for resistance markers linked to second-line antibiotic treatment failure.
The SpeeDx portfolio also includes Plex PCR VHS - a multiplex test for herpes simplex virus (1 and 2), varicella zoster and Treponema pallidum (syphilis). Further tests in the Plex PCR portfolio include plans for a comprehensive multiplex panel for respiratory virus testing as well as a respiratory bacterial infection testing solution.
*available where CE-mark is accepted, not available in the U.S. or A.U.
References:
1. Harris SR et al. Lancet Infect Dis Published online
May 15th 2018.
2. Lahra MM et al. Australian Gonococcal
Surveillance Programme annual report, 2015
3. Heffernan H et al.
Antimicrobial resistance and molecular epidemiology of gonococci in NZ,
2014-5
4. Kirkcaldy RD et al. MMWR Surveillance Summaries July 15,
2016 / 65(7);1–19
5. Read TRH. et al CID June 5 2018
doi.org/10.1093/cid/ciy477.
About SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with
offices in London and the US, and distributors across Europe. SpeeDx
specializes in molecular diagnostic solutions that go beyond simple
detection to offer comprehensive information for improved patient
management. Innovative real-time polymerase chain reaction (qPCR)
technology has driven market-leading multiplex detection and priming
strategies. SpeeDx has a portfolio of CE-IVD kits for detection of
infectious disease pathogens, sexually transmitted infection (STI), and
antimicrobial resistance markers and is currently conducting clinical
trials for FDA clearance in 2019. SpeeDx Resistance
Plus
tests enable Resistance Guided Therapy, improving patient outcomes by
empowering practitioners to make informed clinical decisions.
For
more information about SpeeDx please see: http://plexpcr.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190123005258/en/
Contact:
SpeeDx Madeline O’Donoghue Global Marketing Manager madelineo@speedx.com.au +61 2 9209 4170
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-TSMC24.4.2024 21:31:27 CEST | Press release
TSMC Celebrates 30th North America Technology Symposium with Innovations Powering AI with Silicon Leadership
NV-RIMINI-STREET-INC.24.4.2024 18:51:35 CEST | Press release
Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer
NY-HITHIUM24.4.2024 18:01:34 CEST | Press release
Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System
LTIMINDTREE24.4.2024 17:02:33 CEST | Press release
LTIMindtree Closes FY24 with a Strong Order Inflow of $5.6 Bn; up 15.7% YoY
DE-LYCRA24.4.2024 17:01:33 CEST | Press release
LYCRA® Brand Launches New Customizable Fit Solution at Kingpins Amsterdam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom